Variant report
Variant | nsv1050179 |
---|---|
Chromosome Location | chr11:25793308-25816730 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:11)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:25813617..25816295-chr11:25817467..25820329,2 | K562 | blood: |
(count:11 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-ANO3-3 | chr11:25802028-25802169 | NONHSAT018451 |
2 | lnc-ANO3-3 | chr11:25803176-25803213 | NONHSAT018451 |
3 | lnc-ANO3-3 | chr11:25799241-25799338 | ENSG00000254456 |
4 | lnc-ANO3-3 | chr11:25802028-25802169 | ENSG00000254456 |
5 | lnc-ANO3-3 | chr11:25802028-25802169 | ENSG00000254456 |
6 | lnc-ANO3-3 | chr11:25803176-25803213 | ENSG00000254456 |
7 | lnc-ANO3-3 | chr11:25799241-25799338 | NONHSAT018451 |
8 | lnc-ANO3-3 | chr11:25795717-25795970 | NONHSAT018451 |
9 | lnc-ANO3-3 | chr11:25803176-25803305 | ENSG00000254456 |
10 | lnc-ANO3-3 | chr11:25795717-25795970 | ENSG00000254456 |
11 | lnc-ANO3-3 | chr11:25799241-25799338 | ENSG00000254456 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs567921260 | chr11:25795719-25795720 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
2 | rs137947356 | chr11:25795730-25795731 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
3 | rs536171317 | chr11:25795758-25795759 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
4 | rs371526301 | chr11:25795830-25795831 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
5 | rs150915916 | chr11:25795863-25795864 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
6 | rs561759291 | chr11:25795868-25795869 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
7 | rs575409648 | chr11:25795887-25795888 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
8 | rs34034185 | chr11:25795892-25795893 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
9 | rs570183266 | chr11:25798847-25798848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs537733466 | chr11:25798862-25798863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs11028925 | chr11:25798872-25798873 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
12 | rs552074889 | chr11:25798881-25798882 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544629555 | chr11:25798883-25798884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs144659228 | chr11:25798887-25798888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs139642312 | chr11:25798897-25798898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs373185803 | chr11:25798916-25798917 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs189522117 | chr11:25798923-25798924 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs11028926 | chr11:25798927-25798928 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs144270046 | chr11:25799011-25799012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs11028927 | chr11:25799035-25799036 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs146740210 | chr11:25799057-25799058 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7127430 | chr11:25799090-25799091 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs553450804 | chr11:25799102-25799103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs180767208 | chr11:25799123-25799124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184927409 | chr11:25799124-25799125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs139292294 | chr11:25799138-25799139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530110930 | chr11:25799160-25799161 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs548309696 | chr11:25799164-25799165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs552957572 | chr11:25799175-25799176 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs142593596 | chr11:25799177-25799178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs189308733 | chr11:25799178-25799179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs553776812 | chr11:25799257-25799258 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
33 | rs76304744 | chr11:25799261-25799262 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
34 | rs536339964 | chr11:25799280-25799281 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
35 | rs57735797 | chr11:25799287-25799288 | Inactive region | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs61745808 | chr11:25799334-25799335 | Inactive region | lncRNA | n/a | Overlapped CNVs | n/a |
37 | rs539368073 | chr11:25802018-25802019 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs66644014 | chr11:25802039-25802040 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
39 | rs546782451 | chr11:25802073-25802074 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
40 | rs4923303 | chr11:25802075-25802076 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs573304090 | chr11:25802081-25802082 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
42 | rs532425391 | chr11:25802095-25802096 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
43 | rs4923304 | chr11:25802096-25802097 | Weak transcription | lncRNA | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs555942963 | chr11:25802105-25802106 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
45 | rs574053581 | chr11:25802107-25802108 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
46 | rs569199815 | chr11:25802131-25802132 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
47 | rs183944670 | chr11:25802134-25802135 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
48 | rs188286655 | chr11:25802143-25802144 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
49 | rs192611190 | chr11:25802154-25802155 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
50 | rs556668748 | chr11:25802164-25802165 | Weak transcription | lncRNA | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Burkitt''s lymphoma | 19759907 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Melanoma | 18172304 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Wilms tumour | 21544195 | CNVD |
Parathyroid adenoma | 22454399 | CNVD |
Chordoma | 21602918 | CNVD |
Breast cancer | 21949216 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 19222835 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Beckwith-Wiedemann syndrome | 21518781 | CNVD |
Wilms tumour | 21518781 | CNVD |
Hepatoblastoma | 21518781 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Gastrointestinal stromal cancer | 17535989 | CNVD |
Paraganglioma | 17535989 | CNVD |
Pulmonary chondroma | 17535989 | CNVD |
Gastric cancer | 17908304 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Autism | 22495311 | CNVD |
Prostate cancer | 18632612 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 21785460 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Congenital diaphragmatic hernia | 21525063 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Potocki-Shaffer syndrome | 19222835 | CNVD |
WAGR syndrome | 19222835 | CNVD |
Chordoma | 18071362 | CNVD |
Autism | 22102821 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Bipolar disorder | 19114987 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:25798800-25799200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr11:25802000-25803800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
3 | chr11:25802400-25802600 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
4 | chr11:25815800-25816800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |